Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Apply
A2B694
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step